Find the latest in EPAD news and research
-
|
Read more: EPAD at AD/PD2025The AD/PD™ Alzheimer’s disease and Parkinson’s disease Conference took place between 1-5 April in Vienna, Austria. The conference presented all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug…
All news and research
-
|
Our sister project, Amyloid imaging to prevent Alzheimer’s disease (AMYPAD), which began its activities on October 2016, has recently enrolled its first…
-
|
We are delighted to announce that April was the most successful month to date with 73 new research participants enrolled in the…
-
|
What is your current role in EPAD? I coordinate EPAD at the Edinburgh Trial Delivery Centre, working with a great team…
-
|
The first quarter of 2018 started with great intensity! We were busy working towards opening new sites and improving recruitment. Positive…
-
|
What is your current role in EPAD? As a Data Scientist at Aridhia, I support the development and maintenance of the…
-
|
Dr Vanessa Raymont (pictured) is a senior researcher and consultant psychiatrist working in the Department of Psychiatry at the University of…
-
|
Summary: Biomedical research aimed at the development of therapies for chronic and late‐onset conditions increasingly concentrates on the early treatment of…
-
At, with and beyond risk: expectations of living withthe possibility of future dementia
-
|
We are delighted to announce that March was the most successful month to date with 66 new research participants enrolled in…
-
|
ABSTRACT: Introduction: It is a challenge to find participants for Alzheimer’s disease (AD) prevention trials within a short period of time.…
-
European Prevention of Alzheimer’s Dementia Registry:Recruitment and prescreening approach for a longitudinalcohort and prevention trials
-
|
On 22 March, The Lancet Neurology published an article entitled: “Frederik Barkhof: building bridges between disciplines” where EPAD and its sister…
-
|
CSF Biomarkers in AD, José Luis Molinuevo
-
|
The IMI-EMIF initiative would like to invite you to its public symposium: ‘Liberating Evidence from European Health Data – the Achievements and…
-
The Rationale Behind the New Alzheimer’s DiseaseConceptualization: Lessons Learned During the LastDecades
-
|
Evolving definitions of AD and its stages, Philip Scheltens
-
|
We are very pleased to announce that the Barcelonabeta Brain Research Center (BBRC) was the most successful trial delivery centre (TDC)…
-
|
Summary: In clinical trials which target pathophysiological mechanisms associated with Alzheimer’s disease, research participants who are recruited based on biomarker…
-
|
Review on disease progression models in AD, Michele Potashman
-
|
On 27 February, our partner Alzheimer Europe (AE) held a successful lunch debate entitled “Will we be able to prevent Alzheimer’s…
-
|
The EPAD Academy core team encourages the EPAD Fellows to present their work at national and international scientific conferences and…
No posts were found.
No posts were found.